. Author manuscript; available in PMC: 2010 Jul 1.

Published in final edited form as: Mol Cell Neurosci. 2009 May 3;41(3):337–347. doi: 10.1016/j.mcn.2009.04.007

Table 2.

Quantification of BrdU-labeled and BrdU/S100β double-labeled cells from the CVO regions following BrdU treatment for four weeks.

Region	BrdU⁺ per section^*	S100β⁺/BrdU⁺ per section^*	% S100β ⁺/BrdU⁺ vs. BrdU⁺
OVLT	11.65 ± 3.37	5.20 ± 1.61	45.2 ± 5.23
SFO	15.88 ± 3.82	4.60 ± 1.18	29.6 ± 4.12
ME	35.36 ± 4.22	10.72 ± 1.69	30.3 ± 3.52
AP	34.03 ± 8.68	7.08 ± 1.86	21.7 ± 3.59

Values indicate average number cells immunopositive per section. Data is expressed as mean ± S.E.M.